1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Spain In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Spain In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "Spain In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the Spain In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the Spain In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Spain In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About? 13
2.2 In Vitro Diagnostics Market Segmentation 13
2.3 Definitions of Markets Covered in the Report 16
3 In Vitro Diagnostics Market, Spain 29
3.1 In Vitro Diagnostics Market, Spain, Revenue ($m), 2007-2021 29
3.2 In Vitro Diagnostics Market, Spain, Revenue Mix ($m), 2014 31
3.3 In Vitro Diagnostics Market, Spain, Category Contribution by Revenue ($m), 2014 32
3.4 In Vitro Diagnostics Market, Spain, Category Comparison by Revenue ($m), 2007-2021 34
3.5 In Vitro Diagnostics Market, Spain, Revenue ($m), 2007-2014 36
3.6 In Vitro Diagnostics Market, Spain, Revenue ($m), 2014-2021 38
3.7 In Vitro Diagnostics Market, Spain, Company Share by Revenue ($m), 2014 40
4 Clinical Chemistry Market, Spain 42
4.1 Clinical Chemistry Market, Spain, Revenue Mix ($m), 2014 42
4.2 Clinical Chemistry Market, Spain, Segment Contribution (%), 2014 43
4.3 Clinical Chemistry Market, Spain, Revenue ($m), 2007-2014 45
4.4 Clinical Chemistry Market, Spain, Revenue ($m), 2014-2021 47
4.4.1 Clinical Chemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2007-2014 49
4.4.2 Therapeutic Drug Monitoring Market, Spain, Revenue ($m), by Segment, 2007-2014 51
4.4.3 Urine Analysis Market, Spain, Revenue ($m), by Segment, 2007-2014 53
4.4.4 Clinical Chemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2014-2021 55
4.4.5 Therapeutic Drug Monitoring Market, Spain, Revenue ($m), by Segment, 2014-2021 57
4.4.6 Urine Analysis Market, Spain, Revenue ($m), by Segment, 2014-2021 59
4.5 Clinical Chemistry Market, Spain, Distribution Share by Revenue ($m), 2013-2014 61
4.6 Clinical Chemistry Market, Spain, Company Share by Revenue ($m), 2014 62
5 Genetic Testing Market, Spain 64
5.1 Genetic Testing Market, Spain, Revenue Mix ($m), 2014 64
5.2 Genetic Testing Market, Spain, Segment Contribution (%), 2014 65
5.3 Genetic Testing Market, Spain, Revenue ($m), 2007-2014 66
5.4 Genetic Testing Market, Spain, Revenue ($m), 2014-2021 68
5.5 Genetic Testing Market, Spain, Distribution Share by Revenue ($m), 2013-2014 70
5.6 Genetic Testing Market, Spain, Company Share by Revenue ($m), 2014 71
6 Haematology Market, Spain 73
6.1 Haematology Market, Spain, Revenue Mix ($m), 2014 73
6.2 Haematology Market, Spain, Segment Contribution (%), 2014 74
6.3 Haematology Market, Spain, Revenue ($m), 2007-2014 76
6.4 Haematology Market, Spain, Revenue ($m), 2014-2021 78
6.4.1 Haematology Cell Counters Market, Spain, Revenue ($m), by Segment, 2007-2014 80
6.4.2 Haematology Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2007-2014 82
6.4.3 Haematology Reagents Market, Spain, Revenue ($m), by Segment, 2007-2014 84
6.4.4 Haemostasis Market, Spain, Revenue ($m), by Segment, 2007-2014 86
6.4.5 Immunohaematology Market, Spain, Revenue ($m), by Segment, 2007-2014 88
6.4.6 Haematology Cell Counters Market, Spain, Revenue ($m), by Segment, 2014-2021 90
6.4.7 Haematology Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2014-2021 92
6.4.8 Haematology Reagents Market, Spain, Revenue ($m), by Segment, 2014-2021 94
6.4.9 Haemostasis Market, Spain, Revenue ($m), by Segment, 2014-2021 96
6.4.10 Immunohaematology Market, Spain, Revenue ($m), by Segment, 2014-2021 98
6.5 Haematology Market, Spain, Distribution Share by Revenue ($m), 2013-2014 100
6.6 Haematology Market, Spain, Company Share by Revenue ($m), 2014 101
7 Histology And Cytology Market, Spain 103
7.1 Histology And Cytology Market, Spain, Revenue Mix ($m), 2014 103
7.2 Histology And Cytology Market, Spain, Segment Contribution (%), 2014 104
7.3 Histology And Cytology Market, Spain, Revenue ($m), 2007-2014 105
7.4 Histology And Cytology Market, Spain, Revenue ($m), 2014-2021 107
7.5 Histology And Cytology Market, Spain, Distribution Share by Revenue ($m), 2013-2014 109
7.6 Histology And Cytology Market, Spain, Company Share by Revenue ($m), 2014 110
8 Immuno Chemistry Market, Spain 112
8.1 Immuno Chemistry Market, Spain, Revenue Mix ($m), 2014 112
8.2 Immuno Chemistry Market, Spain, Segment Contribution (%), 2014 113
8.3 Immuno Chemistry Market, Spain, Revenue ($m), 2007-2014 115
8.4 Immuno Chemistry Market, Spain, Revenue ($m), 2014-2021 117
8.4.1 Anemia Tests Market, Spain, Revenue ($m), by Segment, 2007-2014 119
8.4.2 Disease Specific Immunochemistry Market, Spain, Revenue ($m), by Segment, 2007-2014 121
8.4.3 Endocrinology Tests Market, Spain, Revenue ($m), by Segment, 2007-2014 123
8.4.4 IgE Allergy Blood Tests Market, Spain, Revenue ($m), by Segment, 2007-2014 125
8.4.5 Immunochemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2007-2014 127
8.4.6 Immunochemistry Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2007-2014 129
8.4.7 Vitamins Tests Market, Spain, Revenue ($m), by Segment, 2007-2014 131
8.4.8 Anemia Tests Market, Spain, Revenue ($m), by Segment, 2014-2021 133
8.4.9 Disease Specific Immunochemistry Market, Spain, Revenue ($m), by Segment, 2014-2021 135
8.4.10 Endocrinology Tests Market, Spain, Revenue ($m), by Segment, 2014-2021 137
8.4.11 IgE Allergy Blood Tests Market, Spain, Revenue ($m), by Segment, 2014-2021 139
8.4.12 Immunochemistry Analyzers Market, Spain, Revenue ($m), by Segment, 2014-2021 141
8.4.13 Immunochemistry Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2014-2021 143
8.4.14 Vitamins Tests Market, Spain, Revenue ($m), by Segment, 2014-2021 145
8.5 Immuno Chemistry Market, Spain, Distribution Share by Revenue ($m), 2013-2014 147
8.6 Immuno Chemistry Market, Spain, Company Share by Revenue ($m), 2014 148
9 Infectious Diagnostics Market, Spain 150
9.1 Infectious Diagnostics Market, Spain, Revenue Mix ($m), 2014 150
9.2 Infectious Diagnostics Market, Spain, Segment Contribution (%), 2014 151
9.3 Infectious Diagnostics Market, Spain, Revenue ($m), 2007-2014 153
9.4 Infectious Diagnostics Market, Spain, Revenue ($m), 2014-2021 155
9.4.1 Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2007-2014 157
9.4.2 Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), by Segment, 2014-2021 159
9.5 Infectious Diagnostics Market, Spain, Distribution Share by Revenue ($m), 2013-2014 161
9.6 Infectious Diagnostics Market, Spain, Company Share by Revenue ($m), 2014 162
10 Microbiology Culture Market, Spain 164
10.1 Microbiology Culture Market, Spain, Revenue Mix ($m), 2014 164
10.2 Microbiology Culture Market, Spain, Segment Contribution (%), 2014 165
10.3 Microbiology Culture Market, Spain, Revenue ($m), 2007-2014 167
10.4 Microbiology Culture Market, Spain, Revenue ($m), 2014-2021 169
10.4.1 Microbiology Analyzers Market, Spain, Revenue ($m), by Segment, 2007-2014 171
10.4.2 Microbiology Analyzers Market, Spain, Revenue ($m), by Segment, 2014-2021 173
10.5 Microbiology Culture Market, Spain, Distribution Share by Revenue ($m), 2013-2014 175
10.6 Microbiology Culture Market, Spain, Company Share by Revenue ($m), 2014 176
11 Overview of Key Companies in Spain, In Vitro Diagnostics Market 178
11.1 Siemens Healthcare 178
11.1.1 Company Overview 178
11.2 F. Hoffmann-La Roche Ltd. 178
11.2.1 Company Overview 178
11.3 Abbott Laboratories 178
11.3.1 Company Overview 178
11.4 bioMerieux S.A. 179
11.4.1 Company Overview 179
11.5 Becton, Dickinson and Company 179
11.5.1 Company Overview 179
11.6 Danaher Corporation 179
11.6.1 Company Overview 179
11.7 Sysmex Corporation 180
11.7.1 Company Overview 180
11.8 Qiagen N.V. 180
11.8.1 Company Overview 180
11.9 Bio-Rad Laboratories, Inc. 180
11.9.1 Company Overview 180
11.10 Hologic, Inc. 181
11.10.1 Company Overview 181
11.11 Ortho-Clinical Diagnostics Inc. 181
11.11.1 Company Overview 181
11.12 Horiba, Ltd. 181
11.12.1 Company Overview 181
11.13 ELITech Group 182
11.13.1 Company Overview 182
11.14 Alere Inc. 182
11.14.1 Company Overview 182
12 In Vitro Diagnostics Market Pipeline Products 183
13 Financial Deals Landscape 189
13.1 Equity Offerings 189
13.1.1 One Way Liver Genomics to Raise USD0.2 Million in Financing Round 189
13.2 Partnerships 190
13.2.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
13.2.2 Seegene Enters into Co-Development Agreement with BD Life Sciences 191
13.2.3 MdxHealth Enters into Licensing Agreement with Erasmus MC 192
13.2.4 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 193
13.2.5 Sigma-Aldrich Enters into Distribution Agreement with LGC 194
13.2.6 OvaGene Oncology Enters into Agreement with Etta Healthcare 195
13.2.7 InTouch Health Enters into Agreement with iSchemaView 196
13.2.8 Galmed Pharma Enters into Research, Option and Licensing Agreement with One Way Liver Genomics 197
13.2.9 Boston IVF Enters into Agreement with IviGen and iGenomix 198
13.2.10 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 199
13.2.11 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 200
13.2.12 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 201
13.2.13 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 202
13.2.14 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 203
13.2.15 AngioDynamics Enters into Licensing Agreement with EmboMedics 204
13.2.16 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 205
13.2.17 Biocartis Enters into Licensing and Development Agreement with Microbiome 206
13.2.18 Esperite Enters into Agreement with Premaitha Health 207
13.2.19 CBScientific Enters into Distribution Agreement with UTest 208
13.2.20 Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 209
13.2.21 GeneThera Enters into Co-Development Agreement with Hudson Robotics 210
13.2.22 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 211
13.2.23 Ellen Enters into Distribution Agreement with Biosynex 212
13.2.24 KromaTiD Enters into Distribution Agreement with Tebu-bio 213
13.2.25 Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 214
13.2.26 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 216
13.2.27 BioMerieux Enters into Licensing Agreement with Astute Medical 217
13.2.28 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 218
13.2.29 NoemaLife Enters into Distribution Agreement with Horiba Medical 219
13.2.30 Clinical Genomics Enters into Licensing Agreement with CSIRO 220
13.3 Venture Financing 221
13.3.1 Immune Tolerance Raises USD0.2 Million in Equity Crowdfunding 221
14 Recent Developments 222
14.1 Corporate Communications 222
14.1.1 Sep 17, 2015: Oryzon Shareholders Approve Listing to the Spanish Continuous Market 222
14.1.2 Mar 31, 2015: Jacoti ListenApp Now Available in the US! The bridge between audio and hearing aids 222
14.2 Financial Announcements 224
14.2.1 Apr 15, 2015: Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection 224
14.2.2 Mar 03, 2015: Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 225
14.2.3 Feb 26, 2015: Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014 228
14.2.4 Jan 21, 2015: Cohera Medical Enters Agreement with B. Braun Surgical for Distribution of TissuGlu Surgical Adhesive in Select European Countries 231
14.2.5 Nov 04, 2014: Grifols Net Profit Increases By 26.9% To 339 Million Euros In The Nine Months To September 2014 232
14.3 Legal And Regulatory 237
14.3.1 Feb 16, 2015: Grifols PhocusRx Certified DIACAP Compliant 237
14.3.2 Jan 21, 2015: Grifols Academy of Plasmapheresis Awarded ACCET Accreditation 237
14.3.3 Jan 02, 2015: Grifols new immunoglobulin purification plant in the United States receives FDA approval 238
14.4 Other Significant Developments 239
14.4.1 Oct 03, 2015: Merck Serono Awards Grant for Growth Innovation at ESPE in Barcelona 239
14.4.2 Sep 17, 2015: SYGNIS signs distribution agreement with LABGENE Scientific for Switzerland 240
14.4.3 Aug 25, 2015: SYGNIS signs non-exclusive distribution agreement for Australia with GeneWorks 240
14.4.4 Aug 05, 2015: OrSense Re-awarded the Catalan Blood Bank Contract for Pre-donation Hemoglobin Testing 241
14.4.5 Jun 12, 2015: Dr. Elías Campo recieves the Eugenio Rodriguez Pascual Award for his contributions to diagnosis and cancer therapy 241
14.4.6 Jun 11, 2015: SYGNIS signs second non-exclusive distribution agreement for Asia with Welgene Biotech in Taiwan 242
14.4.7 May 04, 2015: SYGNIS signs non-exclusive distribution agreement with Cambridge Bioscience for UK and Ireland 243
14.4.8 Jan 20, 2015: Midatech Biogune completes the refit to adapt to aseptic manufacture 244
14.5 Product News 244
14.5.1 Sep 15, 2015: SYGNIS Announces Global Launch of SunScript One Step Reverse Transcriptase-PCR Kit 244
14.5.2 May 20, 2015: Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients 245
14.5.3 Apr 20, 2015: SYGNIS Announces Global Launch of its Second Product Line: SunScript Reverse Transcriptase 246
14.5.4 Jan 19, 2015: Analytical Methods for biomarkers Anti-IIa, Anti-Xa and TPFI 248
14.5.5 Nov 17, 2014: Developed A Non-Invasive Test That Identifies Patients At Risk Of Kidney Transplant Rejection 248
14.6 Strategy And Business Planning 249
14.6.1 Jun 30, 2015: ISD completes single envelope ‘clad rack' cold storage facility for Spanish pharmaceutical giant Grifols 249
14.6.2 Feb 02, 2015: LABCO and PANGAEA, led by Dr Rafael Rosell, join forces to launch a non-invasive test for monitoring cancer treatment 249
15 Appendix 251
15.1 Research Methodology 252
15.1.1 Coverage 252
15.1.2 Secondary Research 252
15.1.3 Primary Research 252
15.1.4 Company Share Analysis 253
15.1.5 Distribution Share Analysis 253
15.2 GlobalData Consulting 253
15.3 Contact Us 253
15.4 Disclaimer 254

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Spain, Revenue ($m), USD Constant, 2007-2021 30
Table 2: In Vitro Diagnostics Market, Spain, Category Contribution by Revenue ($m), 2014 33
Table 3: In Vitro Diagnostics Market, Spain, Category Comparison by Revenue ($m), USD Constant, 2007-2021 35
Table 4: In Vitro Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 37
Table 5: In Vitro Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Table 6: In Vitro Diagnostics Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 41
Table 7: Clinical Chemistry Market, Spain, Segment Contribution (%), 2014 44
Table 8: Clinical Chemistry Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 46
Table 9: Clinical Chemistry Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 10: Clinical Chemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 11: Therapeutic Drug Monitoring Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 52
Table 12: Urine Analysis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 54
Table 13: Clinical Chemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Table 14: Therapeutic Drug Monitoring Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Table 15: Urine Analysis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Table 16: Clinical Chemistry Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 61
Table 17: Clinical Chemistry Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 63
Table 18: Genetic Testing Market, Spain, Segment Contribution (%), 2014 65
Table 19: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 67
Table 20: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Table 21: Genetic Testing Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 70
Table 22: Genetic Testing Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 72
Table 23: Haematology Market, Spain, Segment Contribution (%), 2014 75
Table 24: Haematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 77
Table 25: Haematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 79
Table 26: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 27: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 28: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 29: Haemostasis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 30: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 31: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Table 32: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 33: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 34: Haemostasis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 35: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Table 36: Haematology Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 100
Table 37: Haematology Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 102
Table 38: Histology And Cytology Market, Spain, Segment Contribution (%), 2014 104
Table 39: Histology And Cytology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 106
Table 40: Histology And Cytology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Table 41: Histology And Cytology Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 109
Table 42: Histology And Cytology Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 111
Table 43: Immuno Chemistry Market, Spain, Segment Contribution (%), 2014 114
Table 44: Immuno Chemistry Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 116
Table 45: Immuno Chemistry Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 118
Table 46: Anemia Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 120
Table 47: Disease Specific Immunochemistry Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 122
Table 48: Endocrinology Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 124
Table 49: IgE Allergy Blood Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 126
Table 50: Immunochemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 128
Table 51: Immunochemistry Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 130
Table 52: Vitamins Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 132
Table 53: Anemia Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Table 54: Disease Specific Immunochemistry Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Table 55: Endocrinology Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Table 56: IgE Allergy Blood Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Table 57: Immunochemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Table 58: Immunochemistry Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Table 59: Vitamins Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 146
Table 60: Immuno Chemistry Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 147
Table 61: Immuno Chemistry Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 149
Table 62: Infectious Diagnostics Market, Spain, Segment Contribution (%), 2014 152
Table 63: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 154
Table 64: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Table 65: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 158
Table 66: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 160
Table 67: Infectious Diagnostics Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 161
Table 68: Infectious Diagnostics Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 163
Table 69: Microbiology Culture Market, Spain, Segment Contribution (%), 2014 166
Table 70: Microbiology Culture Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 168
Table 71: Microbiology Culture Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 170
Table 72: Microbiology Analyzers Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 172
Table 73: Microbiology Analyzers Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 174
Table 74: Microbiology Culture Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014 175
Table 75: Microbiology Culture Market, Spain, Company Share by Revenue ($m), USD Constant, 2014 177
Table 76: In Vitro Diagnostics Market Pipeline Products 183
Table 77: One Way Liver Genomics to Raise USD0.2 Million in Financing Round 189
Table 78: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 190
Table 79: Seegene Enters into Co-Development Agreement with BD Life Sciences 191
Table 80: MdxHealth Enters into Licensing Agreement with Erasmus MC 192
Table 81: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 193
Table 82: Sigma-Aldrich Enters into Distribution Agreement with LGC 194
Table 83: OvaGene Oncology Enters into Agreement with Etta Healthcare 195
Table 84: InTouch Health Enters into Agreement with iSchemaView 196
Table 85: Galmed Pharma Enters into Research, Option and Licensing Agreement with One Way Liver Genomics 197
Table 86: Boston IVF Enters into Agreement with IviGen and iGenomix 198
Table 87: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 199
Table 88: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 200
Table 89: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 201
Table 90: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 202
Table 91: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 203
Table 92: AngioDynamics Enters into Licensing Agreement with EmboMedics 204
Table 93: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 205
Table 94: Biocartis Enters into Licensing and Development Agreement with Microbiome 206
Table 95: Esperite Enters into Agreement with Premaitha Health 207
Table 96: CBScientific Enters into Distribution Agreement with UTest 208
Table 97: Norgine Enters into Distribution Agreement with Arc Medical Design for Endocuff Vision 209
Table 98: GeneThera Enters into Co-Development Agreement with Hudson Robotics 210
Table 99: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 211
Table 100: Ellen Enters into Distribution Agreement with Biosynex 212
Table 101: KromaTiD Enters into Distribution Agreement with Tebu-bio 213
Table 102: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 214
Table 103: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 216
Table 104: BioMerieux Enters into Licensing Agreement with Astute Medical 217
Table 105: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 218
Table 106: NoemaLife Enters into Distribution Agreement with Horiba Medical 219
Table 107: Clinical Genomics Enters into Licensing Agreement with CSIRO 220
Table 108: Immune Tolerance Raises USD0.2 Million in Equity Crowdfunding 221

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Spain, Revenue ($m), USD Constant, 2007-2021 29
Figure 2: In Vitro Diagnostics Market, Spain, Revenue Mix ($m), 2014 31
Figure 3: In Vitro Diagnostics Market, Spain, Category Contribution (%), 2014 32
Figure 4: In Vitro Diagnostics Market, Spain, Category Comparison by Revenue ($m), USD Constant, 2007-2021 34
Figure 5: In Vitro Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 36
Figure 6: In Vitro Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 38
Figure 7: In Vitro Diagnostics Market, Spain, Company Share (%) 2014 40
Figure 8: Clinical Chemistry Market, Spain, Revenue Mix ($m), 2014 42
Figure 9: Clinical Chemistry Market, Spain, Segment Contribution (%), 2014 43
Figure 10: Clinical Chemistry Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 45
Figure 11: Clinical Chemistry Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 12: Clinical Chemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 13: Therapeutic Drug Monitoring Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 51
Figure 14: Urine Analysis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 53
Figure 15: Clinical Chemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 55
Figure 16: Therapeutic Drug Monitoring Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Figure 17: Urine Analysis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Figure 18: Clinical Chemistry Market, Spain, Company Share (%) 2014 62
Figure 19: Genetic Testing Market, Spain, Revenue Mix ($m), 2014 64
Figure 20: Genetic Testing Market, Spain, Segment Contribution (%), 2014 65
Figure 21: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 66
Figure 22: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 68
Figure 23: Genetic Testing Market, Spain, Company Share (%) 2014 71
Figure 24: Haematology Market, Spain, Revenue Mix ($m), 2014 73
Figure 25: Haematology Market, Spain, Segment Contribution (%), 2014 74
Figure 26: Haematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 76
Figure 27: Haematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Figure 28: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 80
Figure 29: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 82
Figure 30: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 84
Figure 31: Haemostasis Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 86
Figure 32: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 88
Figure 33: Haematology Cell Counters Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 90
Figure 34: Haematology Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 92
Figure 35: Haematology Reagents Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 94
Figure 36: Haemostasis Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 96
Figure 37: Immunohaematology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 98
Figure 38: Haematology Market, Spain, Company Share (%) 2014 101
Figure 39: Histology And Cytology Market, Spain, Revenue Mix ($m), 2014 103
Figure 40: Histology And Cytology Market, Spain, Segment Contribution (%), 2014 104
Figure 41: Histology And Cytology Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 105
Figure 42: Histology And Cytology Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 107
Figure 43: Histology And Cytology Market, Spain, Company Share (%) 2014 110
Figure 44: Immuno Chemistry Market, Spain, Revenue Mix ($m), 2014 112
Figure 45: Immuno Chemistry Market, Spain, Segment Contribution (%), 2014 113
Figure 46: Immuno Chemistry Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 115
Figure 47: Immuno Chemistry Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 117
Figure 48: Anemia Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 119
Figure 49: Disease Specific Immunochemistry Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 121
Figure 50: Endocrinology Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 123
Figure 51: IgE Allergy Blood Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 125
Figure 52: Immunochemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 127
Figure 53: Immunochemistry Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 129
Figure 54: Vitamins Tests Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 131
Figure 55: Anemia Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 133
Figure 56: Disease Specific Immunochemistry Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 135
Figure 57: Endocrinology Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 137
Figure 58: IgE Allergy Blood Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 139
Figure 59: Immunochemistry Analyzers Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 141
Figure 60: Immunochemistry Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 143
Figure 61: Vitamins Tests Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 145
Figure 62: Immuno Chemistry Market, Spain, Company Share (%) 2014 148
Figure 63: Infectious Diagnostics Market, Spain, Revenue Mix ($m), 2014 150
Figure 64: Infectious Diagnostics Market, Spain, Segment Contribution (%), 2014 151
Figure 65: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 153
Figure 66: Infectious Diagnostics Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 155
Figure 67: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 157
Figure 68: Infectious Diagnostics Rapid Tests and POC Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 159
Figure 69: Infectious Diagnostics Market, Spain, Company Share (%) 2014 162
Figure 70: Microbiology Culture Market, Spain, Revenue Mix ($m), 2014 164
Figure 71: Microbiology Culture Market, Spain, Segment Contribution (%), 2014 165
Figure 72: Microbiology Culture Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 167
Figure 73: Microbiology Culture Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 169
Figure 74: Microbiology Analyzers Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014 171
Figure 75: Microbiology Analyzers Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021 173
Figure 76: Microbiology Culture Market, Spain, Company Share (%) 2014 176

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.